Microvascular disease-the Cinderella of uraemic heart disease

Nephrology Dialysis Transplantation

Volumn 15, Issue 10, 2000, Pages 1493-1503

  Amann, Kerstin ^a,c   Ritz, Eberhard ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Department of Pathology ^*  (Germany)

Author keywords

Coronary heart disease; Heart capillaries; Myocardial infarction; Uraemia; Uraemic cardiomyopathy

Indexed keywords

ANGIOGENESIS; ARTERIOLE; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD PRESSURE; CAPILLARY; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; CORONARY ARTERY; HEART ARRHYTHMIA; HEART DEATH; HEART DISEASE; HEART FAILURE; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HUMAN; HYPOXIA; KIDNEY FAILURE; MICROANGIOPATHY; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; UREMIA; VASCULAR DISEASE;

EID: 0033814581     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.10.1493     Document Type: Article

References (86)

1. Accelerated atherosclerosis in prolonged maintenance hemodialysis
2. Report on management of renal failure in Europe, XXII, 1991
3. Morbidity and mortality due to hypertension in patients with renal failure
4. Occurence and significance of heart disease in uraemia
5. Cardiovascular changes in chronic hemodialysis patients
6. Poor long-term survival after acute myocardial infarction among patients on long-term dialysis
7. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans
8. Reduction of coronary reserve: A mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries
9. Impairment of cardiac function and energetics in experimental renal failure
10. Myocardial blood flow, glucose uptake and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hybernation
11. Chronic myocardial hybernation in humans. From bedside to bench
12. Glucose uptake and expression of glucose transporters in the heart of uremic rats
13. Cardiovascular complications in renal failure
14. Cardiac pathology in patients with end-stage renal disease maintained on hemodialysis
15. Dialysis-associated ischemic heart disease: Insights from coronary angiography
16. Survival and predictors of death in dialysed diabetic patients
17. Arterial calcification and pathology in uremic patients undergoing dialysis
18. Morphology of coronary atherosclerotic lesions in patients with chronic renal failure
19. Composition and classification of human atherosclerotic lesions
20. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study
21. Which causes of death are related to hyperphosphatemia in hemodialysis (HD) patients?
22. Hyperphosphataemia - A silent killer of patients with renal failure
23. Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients
24. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis
25. Percutaneous coronary angioplasty (PTCA) or coronary artery bypass grafting (CABG) - Which is the appropriate therapy of coronary artery disease in uraemic patients?
26. Long-term outcome of dialysis patients in the United States with coronary revascularization procedures
27. Atherosclerosis - An inflammatory disease
28. Cardiovascular disease, fibrinogen and the acute phase response: Associations with lipids and blood pressure in patients with chronic renal disease
29. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
30. C-Reactive protein predicts all-cause and cardiovascular mortality in hemodialysis patients
31. Complement and components as uremic toxins and their potential role as mediators of microinflammation
32. Lack of epicardial coronary vasodilatator capacity in hemodialysis (HD) patients
33. Evidence in vivo showing increase of vaseline NO and decrease of stimulated NO generation in normotensive patients on chronic hemodialysis
34. Total nitric oxide production is low in patients with chronic renal disease
35. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
36. Concentration of dimethyl-l-arginine in the plasma of patients with end-stage renal failure
37. Endothelin receptor antagonists influence cardiovascular morphology in uremic rats
38. Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats
39. Endothelin and cardiovascular remodelling in end-stage renal disease
40. Flow and arterial remodeling in renal failure-effect of endothelin receptor blockade
41. Vascular access stenosis: Prospects for prevention and therapy
42. Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension
43. Effects of nifedipine and moxonidine on cardiac structure in spontaneously hypertensive rats (SHR-SP) - Stereological studies on myocytes, capillaries, arteries and cardiac interstitium
44. Improvement of coronary flow reserve after long-term therapy with enalapril
45. Changes of vascular architecture independent of blood pressure in experimental uremia
46. Aortic changes in experimental renal failure-hyperplasia of hypertrophy of smooth muscle cells?
47. Hypertrophy of intramyocardial arteriolar smooth muscle cells in experimental renal failure
48. Arteriolar wall thickening, capillary rarefaction and interstitial fibrosis in the heart of rats with renal failure: The effect of ramipril, nifedipine and moxonidine
49. Endothelin A receptor blockade prevents capillary/myocyte mismatch in the heart of uremic animals
50. Relation between myocardial blood flow and the severity of coronary artery stenosis
51. Effect of aging on myocardial perfusion reserve
52. Cardiovascular abnormalities in ageing and in uraemia-only analogy or shared pathomechanisms?
53. Aortic and large artery compliance in end-stage renal failure
54. Influence of arterial pulse and reflected waves on blood pressure and cardiac function
55. Reduced capillary density in the myocardium of uremic rats - A stereological study
56. Myocyte/capillary mismatch in the heart of uremic patients
57. Reduction of capillary supply in uremic left ventricular hypertrophy is prevented by a selective endothelin receptor antagonist (ET(A)-RA)
58. Capillary/myocyte mismatch in the heart in renal failure - A role for erythropoietin?
59. Capillary deficit in the heart, but not in skeletal muscle, of rats with moderate renal failure
60. Cutaneous abnormalities in uremic patients
61. Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188
62. Therapeutic angiogenesis for heart failure
63. Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: Effect on myocardial angiogenesis
64. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium
65. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy
66. Treatment of acute limb ischemia by intramuscular injection of vascular endothelial growth factor gene
67. Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion
68. Vasculogenesis, angiogenesis, and growth factors: Ephrins enter the fray at the border
69. Mechanisms of angiogenesis
70. Mechanisms of angiogenesis and arteriogenesis
71. Postnatal growth of the heart and its blood vessels
72. Morphometry of human coronary capillaries during normal growth and the effect of age in left ventricular pressure-overload hypertrophy
73. VEGF mediates angioblast migration during development of the dorsal aorta in Xenopus
74. Multiple forms of angiostatin induce apoptosis in endothelial cells
75. Recombinant kringle 1-3 of plasminogen inhibits rabbit corneal angiogenesis induced by angiogenin
76. Endostatin: A promising drug for antiangiogenic therapy
77. Calreticulin and calreticulin fragments are endothelial cell inhibitors that suppress tumor growth
78. Cardiac remodeling in experimental renal failure-an immunohistochemical study
79. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease
80. Two fgf-2 genes are necessary for normal cardiac capillarisation
81. Hypoxia and endothelin-1 induce VEGF production in human vascular smooth muscle cells
82. Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells
83. Endothelial cell responses to hypoxic stress
84. A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?
85. Cardiovascular structural changes in uremia - Implications for cardiovascular function